Thalassemias | August 15, 2024
New insights into thalassemia: Latest studies using Devyser Thalassemia for NGS testing
Find out more
Thalassemias
One-size-fits-all: Addressing hemoglobinopathy using NGS
Streamlining Thalassemia Genetic Testing with NGS: Insights from Cyprus
NGS testing in clinical practice - what to expect
Staffing requirements
Challenges in Thalassemia diagnosis
Thalassemia is typically caused by sequence variants in the HBA1, HBA2 or HBB genes. The common...
Changing needs for thalassemia testing and how it will impact clinical labs
Thalassemia is an inherited blood disorder with a worldwide prevalence of nearly 300,000 per year....
Alpha- and beta-thalassemia – can one test meet all needs?
Alpha- and beta-thalassemia are distinct hematologic disorders caused by a defect in globin chain...
CRISPR-Cas9 presents new possibilities for Thalassemia treatment.
The autosomal recessive inherited blood disorder, b-thalassemia, is caused by reduced or absent...
About Thalassemia
Causes Thalassemias are haemoglobinopathies characterised by an abnormal haemoglobin production...
Sequence planning
Devyser offers an online Sequence Coverage Calculator to help plan your NGS run for optimal...
The NGS workflow
Library preparation
Genetic testing for alpha and beta thalassemia testing just got a lot easier. One patient – one reaction
Genetic testing has always been central to the thalassemia patient journey. However, conventional...